期刊文献+

Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases 被引量:36

Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases
原文传递
导出
摘要 Background Chronic active Epstein-Barr virus infection (CAEBV) has been previously reported to be sometimes associated with an aggressive clinical course. The characteristics of CAEBV in Mainland Chinese pediatric patients are largely unreported. The main aims of this survey were to recognize the clinical features of CAEBV in children and to explore its diagnostic criteria and risk factors. Methods A retrospective study was performed on 53 pediatric patients (36 boys and 17 girls) with CAEBV who were admitted to Beijing Children's Hospital between 2003 and 2007. All their medical records were reviewed and analyzed. For each patient, demographic, clinical, laboratory data and outcome were collected. Independent-samples t test was used for statistical analysis. Results The age at onset of CAEBV was from 2 months to 14.6 years (mean (5.3_+3.3) years). At the time of onset, 43.4% patients had an infectious mononucleosis-like symptom. Most patients exhibited intermittent fever (92.5%, 49/53), hepatomegaly (81.1%, 43/53) and splenomegaly (77.4%, 41/53). Life-threatening complications including hemophagocytic syndrome (24.5%,13/53), interstitial pneumonia (24.5%, 13/53), hepatic failure (15.1%, 8/53) and malignant lymphoma (11.3%, 6/53) were also observed. The serum EBV DNA level in 23 patients with CAEBV was in the range of 5.05×10^2-4.60×10^6 copies/ml with a mean value of 103.7 copies/ml. Many patients with CAEBV generally had continuous symptoms during the observational period. Eleven out of 42 patients (26.2%) died 7 months to 3 years after onset. Deceased patients were more likely to have had lower platelet counts and albumin levels than the living patients (P 〈0.05 for all comparisons). Conclusions The study reveals that CAEBV in Chinese pediatric patients has a severe clinical course and prognosis is poor. Thrombocytopenia and decreases in albumin might potentially be risk factors for a poor prognosis. EBV loads should be measured and tissue should be s Background Chronic active Epstein-Barr virus infection (CAEBV) has been previously reported to be sometimes associated with an aggressive clinical course. The characteristics of CAEBV in Mainland Chinese pediatric patients are largely unreported. The main aims of this survey were to recognize the clinical features of CAEBV in children and to explore its diagnostic criteria and risk factors. Methods A retrospective study was performed on 53 pediatric patients (36 boys and 17 girls) with CAEBV who were admitted to Beijing Children's Hospital between 2003 and 2007. All their medical records were reviewed and analyzed. For each patient, demographic, clinical, laboratory data and outcome were collected. Independent-samples t test was used for statistical analysis. Results The age at onset of CAEBV was from 2 months to 14.6 years (mean (5.3_+3.3) years). At the time of onset, 43.4% patients had an infectious mononucleosis-like symptom. Most patients exhibited intermittent fever (92.5%, 49/53), hepatomegaly (81.1%, 43/53) and splenomegaly (77.4%, 41/53). Life-threatening complications including hemophagocytic syndrome (24.5%,13/53), interstitial pneumonia (24.5%, 13/53), hepatic failure (15.1%, 8/53) and malignant lymphoma (11.3%, 6/53) were also observed. The serum EBV DNA level in 23 patients with CAEBV was in the range of 5.05×10^2-4.60×10^6 copies/ml with a mean value of 103.7 copies/ml. Many patients with CAEBV generally had continuous symptoms during the observational period. Eleven out of 42 patients (26.2%) died 7 months to 3 years after onset. Deceased patients were more likely to have had lower platelet counts and albumin levels than the living patients (P 〈0.05 for all comparisons). Conclusions The study reveals that CAEBV in Chinese pediatric patients has a severe clinical course and prognosis is poor. Thrombocytopenia and decreases in albumin might potentially be risk factors for a poor prognosis. EBV loads should be measured and tissue should be s
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第3期262-266,共5页 中华医学杂志(英文版)
基金 This study was supported by the grants from Beijing Natural Science Foundation (No. 7072026) and the Scientific Research Program of Beijing Municipal Commission of Education (No. KM200710025023).Acknowledgments: We are grateful to Prof. ZHAORI Ge-tu for a critical reading of the manuscript. We are also grateful to the anonymous peer-reviewers whose constructive comments have significantly improved this paper.
关键词 chronic active Epstein-Barr virus infection clinical features risk factors chronic active Epstein-Barr virus infection clinical features risk factors
  • 相关文献

参考文献19

  • 1Cohen JI.Epstein-Barr virus infection.N Engl J Med 2000; 343:481-492. 被引量:1
  • 2de Boer M,Mol MJ,Bogman MJ,Galama JM,Raymakers RA.Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency.Neth J Med 2003; 61:376-382. 被引量:1
  • 3Straus SE.The chronic mononucleosis syndrome.J Infect Dis 1988; 157:405-412. 被引量:1
  • 4Wakiguchi H.Overview of Epstein-Barr virus-associated diseases in Japan.Crit Rev Oncol Hematol 2002; 44:193-202. 被引量:1
  • 5Chiba T,Goto S,Yokosuka O,Imazeki F,Tanaka M,Fukai K,et al.Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis.Eur J Gastroenterol Hepatol 2004; 16:225-228. 被引量:1
  • 6Shibuya A,Tsuchihashi T,Watanabe M,Nakazawa T,Takeuchi A,Sakurai K,et al.Severe chronic active Epstein-Barr virus infection associated with multiple necrotic lesions in the liver.Hepatol Res 2003; 25:447-454. 被引量:1
  • 7Fujieda M,Wakiguchi H,Hisakawa H,Kubota H,Kurashige T.Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents.Acta Paediatr Jpn 1993; 35:394-399. 被引量:1
  • 8Maia DM,Peace-Brewer AL.Chronic,active Epstein-Barr virus infection.Curr Opin Hematol 2000; 7:59-63. 被引量:1
  • 9Savoldo B,Huls MH,Liu Z,Okamura T,Volk HD,Reinke P,et al.Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.Blood 2002; 100:4059-4066. 被引量:1
  • 10Kimura H.Pathogenesis of chronic active Epstein-Barr virus infection:is this an infectious disease,lymphoproliferative disorder,or immunodeficiency? Rev Med Virol 2006; 16:251-261. 被引量:1

同被引文献141

引证文献36

二级引证文献539

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部